Tocilizumab and rituximab reduce relapse rates and disability progression in NMOSD, with tocilizumab provides extra benefits in MOGAD.
Objective Myelin oligodendrocyte glycoprotein-associated disorders (MOGADs) are a rare new neurological autoimmune disease with unclear pathogenesis. Since a linkage of the disease to the human ...
1 Department of Neurology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China 2 Department of First Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi, China ...
Background Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently described demyelinating disorder, and children represent about 50% of all cases. Almost half of the ...
To facilitate the accurate identification of clinical characteristics associated with myelin oligodendrocyte glycoprotein (MOG) antibody positive encephalitis in children presenting with normal brain ...
Early, accurate diagnosis is critical, with AQP4 antibody testing essential to distinguishing NMOSD from similar conditions like MS and myelin oligodendrocyte glycoprotein antibody–associated disease.
Our primary focus is on MS, but we also conduct research into myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), narcolepsy, and epilepsy. Our mission is to advance knowledge on ...
A discovery led by OHSU was made possible by years of study conducted by University of Portland undergraduates. Scientists ...
Medical Xpress on MSN9d
The ‘Silent’ X Chromosome Gives the Aging Female Brain a BoostWhy do women's brains fare better in aging than men's? A study found that the second, 'silent' X chromosome turns on in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback